Markets

CARE Ratings Limited Announces Joint Venture to Enable Global Capability Centres CARE Ratings Limited announced the formation of a joint venture, tentatively named 'Operus Limited,' in collaboration with Vestian Global Work Place Services Private Limited. The Strategy and Investment Committee of CARE Ratings approved the incorporation on March 17, 2026.The joint venture aims to provide Global Capability Centre (GCC) enablement services, assisting global enterprises in designing, establishing, and operating GCCs in India. Services will include strategy, operating model design, talent acquisition, workspace setup, and regulatory compliance. Operus will offer managed services and scalable business models aligned with clients' long-term...

De Nora India Limited Board Approves Material Related Party Transactions De Nora India Limited announced on March 17, 2026, that its Board of Directors approved material related party transactions with Industrie De Nora S.p.A., Italy. The transactions are valued at a maximum of Rs. 2,080 lakhs for the financial year 2026-27 and are subject to shareholder approval.The company will be seeking approval from its members through a postal ballot, which will be delivered electronically to registered email addresses as of March 20, 2026.Remote e-voting for the proposed resolution will be available from April 1, 2026, at 9:00 AM (IST) to April 30, 2026, at 5:00 PM (IST). Shareholders holding shares as of the cutoff date of March 20, 2026...

Mangalam Drugs and Organics Limited Discloses Default on Bank Loans Mumbai – March 17, 2026 – Mangalam Drugs and Organics Limited announced today that it has defaulted on loan obligations to Bank of Baroda and Bank of Maharashtra for a period exceeding 30 days. The disclosure is made in accordance with SEBI's Listing Obligations and Disclosure Requirements.As of March 15, 2026, the company has outstanding amounts due to the banks as detailed in the table below:Sr.NoLoan Account Number- Cash Credit A/c. No.Name of BankAmount Overdue (Rs. In Lacs)Date of Start of Default160383561246Bank of Maharashtra9792117/10/2025204170500000243Bank of Baroda606.0820/10/2025The company is currently working to arrange payment of the...

Kilitch Drugs (India) Limited Sets Record Date for Bonus Equity Share Issue Kilitch Drugs (India) Limited has announced a 1:1 bonus equity share issue, meaning one bonus share for every share held. The record date for determining eligible shareholders has been established as Tuesday, March 24, 2026.Shareholders registered with the company's register of members for physical shares, and those held electronically through depositories, as of the closing hours of March 24, 2026, will be entitled to receive the bonus shares. The bonus shares have a face value of 10 Indian Rupees each.According to a filing, the deemed date of allotment for the bonus equity shares will be Wednesday, March 25, 2026, in accordance with a SEBI circular dated...

Bharat Electronics Limited Secures Orders Worth Rs. 1011 Crore Bharat Electronics Limited (BEL), a Navratna Defence Public Sector Undertaking, has secured additional orders worth Rs. 1011 Crore since February 25, 2026.The orders include communication equipment, radar warning and jamming systems, fire control systems, electro optic sights, fire detection & warning systems for fighter aircraft, high energy lasers, automatic train supervision systems, headup displays, software solutions, jammers, shelters, strategic components, upgrades, spares, and services.Source:

Damodar Industries Limited Appoints New Directors and Compliance Officer Damodar Industries Limited announced several key appointments following a board meeting held on March 17, 2026. The meeting commenced at 1:30 PM and concluded at 3:15 PM.Among the decisions made, the company appointed Mr. Suresh Narayan Nayak as an additional director in the Non-Executive Independent category. Mr. Nayak’s appointment is effective March 17, 2026, and his term will continue until March 16, 2031, subject to shareholder approval. Mr. Nayak brings expertise in banking operations, retail banking, and RBI compliance. He has held leadership roles with YES BANK, Axis Bank, HDFC Bank, and Syndicate Bank.Additionally, the board appointed Vishal N Manseta...

Bajaj Healthcare Limited Announces Sale of Undertaking to Bethany Pharmacare Bajaj Healthcare Limited announced on March 17, 2026, that it has signed a Deed of Assignment and Transfer with Bethany Pharmacare Private Limited for the sale of an undertaking located at Plot No. L-9/3, MIDC, Tarapur, Taluka Boisar, District Palghar, Maharashtra.The transaction, which does not involve any related parties, will result in a consideration of approximately Rs. 2.50 Crores. The completion of the sale is contingent upon the fulfillment of conditions outlined in the Deed of Assignment and Transfer.The undertaking was not operational during the last financial year, resulting in nil turnover or revenue contribution.Shareholders had previously...

Ethos Limited Opens New Boutique in Kanpur, Expanding Retail Presence Ethos Limited has inaugurated a new Ethos Watch Boutique in Kanpur, Uttar Pradesh, marking a key step in the company’s strategy to expand its luxury retail footprint. The new boutique is located at G-12 & 13, Z square, Mall Rd, Downtown, Kanpur, Uttar Pradesh 208001.This expansion strengthens Ethos Limited’s luxury brand portfolio and reinforces its position within a prominent luxury retail market in India. The company aims to make exclusive global brands more accessible to discerning customers across the country.With this latest launch, Ethos Limited now operates a total of 91 boutiques throughout India.Shubham Kandhway, Company Secretary & Compliance Officer...

Gravity India Ltd. Receives In-Principle Approval for Rights Issue Gravity India Ltd. announced on March 17, 2026, that it has received in-principle approval from the Bombay Stock Exchange (BSE) for a proposed rights issue of equity shares. The approval was conveyed in a letter dated March 16, 2026, reference number LOD/RIGHT/HC/FIP/1893/2025-26.The BSE’s permission allows Gravity India Ltd. to use the exchange's name in its Letter of Offer, provided the company includes a disclaimer clause as outlined by the BSE in all related advertisements. The BSE clarified that this permission does not constitute a certification of the contents of the Letter of Offer or guarantee the listing or continued listing of the company's securities.The...

Setco Automotive Subsidiary Secures Extension for NCD Maturity Date Setco Automotive Limited announced that its subsidiary, Setco Auto Systems Private Limited (SASPL), has received approval to extend the maturity date of its Non-Convertible Debentures (NCDs). The extension was approved through a circular resolution dated March 17, 2026, by the Board of Directors of SASPL, with the consent of the Debenture Holders and the Debenture Trustee.The maturity/redemption dates of the NCDs have been extended from March 31, 2026, to May 31, 2026. This adjustment is subject to receiving necessary in-principle approval(s) from the Stock Exchange(s).Source:

Indo Rama Synthetics (India) Limited Sets Cut-off Date for Postal Ballot Indo Rama Synthetics (India) Limited announced that its Board of Directors approved a Postal Ballot Notice on March 17, 2026, seeking shareholder approval for several resolutions. The resolutions include the appointment of Mr. Vipin Kumar as a Non-Executive, Non-Independent Director and Mr. Sanjay Gupta as a Whole-Time Director.March 20, 2026, has been designated as the cut-off date to determine member eligibility for electronic and postal voting. The company will distribute the Postal Ballot Notice, accompanied by an explanatory statement and detailed voting instructions, to registered members as of the cut-off date. The company’s stock code is NSE: INDORAMA and...

AstraZeneca India Receives Approval for Expanded Imfinzi Indication AstraZeneca Pharma India Limited announced on March 16, 2026, that it has received permission from the Central Drugs Standard Control Organisation, Directorate General of Health Services, Government of India, to import and distribute Durvalumab Solution for Infusion 120 mg/2.4 mL and 500 mg/10 mL, marketed as Imfinzi, for an additional indication.The approval allows for the treatment of patients with unresectable hepatocellular carcinoma (uHCC) who have not received prior systemic therapy. This expanded indication paves the way for the marketing of Imfinzi in India, pending receipt of related statutory approvals.Source:

Tembo Global Industries Schedules Investor Meeting and Plant Visit Tembo Global Industries Limited announced a scheduled meeting and plant visit with investors and analysts for Friday, March 20, 2026, beginning at 2:30 PM.The company, trading under the symbol TEMBO (ISIN: INE869Y01010) on the National Stock Exchange of India Limited, stated that the discussions will be based on publicly available information and will not involve any unpublished price-sensitive information.The meeting is being held according to company practices for fair disclosure of unpublished price-sensitive information.Source:

Regency Fincorp Limited Receives Listing Approval for 66,20,201 Equity Shares Regency Fincorp Limited, formerly known as Regency Investments Limited, announced it has received listing approval from the BSE Limited for 66,20,201 equity shares. The shares, each with a face value of Rs. 10 and issued at a premium of Rs. 12, bear distinctive numbers from 73550871 to 80171071. These shares were issued to promoters and non-promoters on a preferential basis following the conversion of warrants.The BSE Limited’s approval, conveyed in letter no. LOD/PREF/RB/FIP/1887/2025-26 dated March 16, 2026, permits the shares to be dealt with on the exchange.According to the BSE, Regency Fincorp Limited is required to comply with Regulation 167 of the...

India Glycols Limited Receives Interim Dividend from Joint Venture India Glycols Limited announced on March 17, 2026, that its joint venture, Clariant IGL Specialty Chemical Private Limited, has declared an interim dividend. The company, along with its wholly-owned subsidiary, holds a 49% share in the joint venture.The interim dividend amounted to Rs. 36,000 per equity share with a face value of Rs. 10. As a result, India Glycols Limited received Rs. 36 crore gross (net of tax deductions of Rs. 32.40 crore), while its wholly-owned subsidiary received Rs. 2.88 crore gross (net of tax deductions of Rs. 2.59 crore).Source:

Gillette India Announces Leadership Change in Human Resources Gillette India Limited announced changes to its senior management team on March 17, 2026. Srinivas Maruthi Patnam, the company’s head of Human Resources, is leaving the company on March 31, 2026, to pursue other interests.Robin Thadathil will assume the role of head of Human Resources, effective April 1, 2026. Mr. Thadathil brings over 16 years of experience in Human Resources with Procter & Gamble, spanning roles across Singapore, the US, and Southeast Asia. His prior roles included leadership positions for commercial teams, manufacturing plants, and country HR functions. Most recently, he led Human Resources for the Malaysia, Singapore, and Vietnam businesses, and served as...

ASI Industries Ltd. Acquires Stake in Lloyds Metals and Energy Ltd. ASI Industries Ltd. announced the acquisition of equity shares in Lloyds Metals and Energy Ltd. for investment purposes. The acquisition was completed on March 16, 2026.ASI Industries Ltd. acquired 30,000 shares, representing 0.006% of the shareholding in Lloyds Metals and Energy Ltd. The total cost of the acquisition amounted to Rs. 3.38 Crores, paid via cash consideration.Lloyds Metals & Energy Ltd. operates in the Steel and Mining Sector. As of March 31, 2025, the company reported a turnover of Rs. 6721.40 Crore, a profit after tax of Rs. 1450.95 Crore, and a net worth of Rs. 6403.08 Crore. The company was established on April 5, 1977, and is a prominent Indian...

Taparia Tools Ltd. Receives Favorable Order from GST Department Taparia Tools Ltd. announced on March 17, 2026, that the Office of the Commissioner of Central GST & Central Excise, Nashik, has dropped penalty proceedings related to a previous notice.The company received a Show Cause cum Demand Notice on September 13, 2025. Following verification of purchase documents, banking transactions, and production records, the GST Department concluded the investigation.The alleged amount involved in the proceedings was 1,30,76,422. The order from the GST department noted the company’s provision of relevant purchase and banking records, the demonstration of genuine manufacturing and supply activities through production data, and the...

Cian Healthcare Ltd. Acquires Significant Stake Through Preferential Allotment Cian Healthcare Limited announced a substantial acquisition of shares through a preferential allotment, as detailed in disclosures filed with the BSE Limited. Ananta Medicare Limited, along with Mr. Rajesh Jain and Mr. Pradeep Kumar Jain, acting in concert, have increased their stake in the company.Details of the Acquisition: The acquisition involved a preferential allotment of equity shares, as per a Resolution Plan approved by the National Company Law Tribunal, Mumbai, on December 18, 2025.DetailAnanta Medicare Limited (Acquirer) & PACsAnanta Medicare Limited (Acquirer) & PACsAnanta Medicare Limited (Acquirer) & PACsShares carrying voting rights...

Vivanza Biosciences Limited Announces Director Resignation Vivanza Biosciences Limited announced on March 17, 2026, the resignation of Hemant Amrish Parikh (DIN: 00027820) as a Non-Executive Director, effective March 17, 2026. The resignation is due to personal reasons.Mr. Parikh confirmed that there are no material reasons for his resignation beyond those stated in his resignation letter.Details of the Resignation:DetailInformationReason for ChangeResignation due to personal reasons.Date of CessationMarch 17, 2026Jayendra Mehta, Managing Director (DIN: 08210602), confirmed the resignation.Source: